EXCLUSIVE: Verano Holdings Unpacks Key Strategies Behind the Company's Accelerated Growth in the Cannabis Space

 Aaron Miles, chief investment officer of Verano Holdings

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Verano Holdings VRNO VRNOF, a vertically-integrated, multistate cannabis operator in the U.S., says it is devoted to improving communal wellness by providing responsible access to regulated cannabis products.

With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands: Verano™, Avexia™, Encore™, and MÜV™.

Verano’s portfolio encompasses 14 U.S. states, with active operations in 11 and 10 production facilities comprising approximately 832,000 square feet of cultivation, including a 26,000-square-foot facility in Massachusetts nearing completion of construction.

Verano designs, builds, and operates dispensaries under retail brands Zen Leaf™ and MÜV™ — delivering what the company describes as a superior cannabis shopping experience in medical and adult-use markets.

Verano Holdings Chief Investment Officer Aaron Miles, speaking at the Benzinga Cannabis Capital Conference in October, unwrapped some of the key strategies behind the company’s growth so far.

Watch the Full Interview

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.